Enable JavaScript to ensure website accessibility Skip to content
Precipio Precipio
  • About Us
    • Our Culture
    • News
    • Careers
    • Scientific Advisors
    • Management Team
    • Board of Directors
  • Products
    • Molecular Kits
      • MPN Panel
      • BCR-ABL1 Panel
      • ABL1 Resistance Panel
      • Rapid AML Panel
      • CLL Panel
      • Cytopenia Panel
    • IV-Cell Cytogenetics Media
      • IV-Cell Cytogenetics Media
    • Resources
      • Brochures
      • Case Studies
      • Instructions For Use
      • Instructions For Use – CE (Europe)
      • Sample Reports
      • FAQs
  • Clinical Services
    • Hematopathology Services
      • Test Menu
      • Sample Reports
      • Proprietary Technologies
      • Meet Our Hematopathologists
    • Resources
      • Brochures
      • Case Studies
      • Sample Reports
      • FAQs
  • Investors
    • Press Releases
    • Media
    • SEC Filings
    • Subscription
    • Investor FAQs
    • Corporate Governance
    • Business Update Calls
    • ESG Policy
  • Contact
  • My Account
    • Login IconCaseVu
    • Login IconShop
    • Login IconPatient Bill Pay
  • $0.00 0
    Cart
  • 0

CASE STUDIES

DNA Icon

Case Studies:

Bloodhound MPN Panel Detects JAK2 Exon 13 Mutation Missed by Single Gene Test Method

Omnia™ Enables Rapid, Cost Effective Diagnosis of MDS With Peripheral Blood Instead of Bone Marrow

Omnia™ Identifies Mixed Phenotype Patient with Aggressive MDS Transformation and MPN

Omnia™ Specifies Rare Hairy Cell Leukemia Variant and Uncovers Unsuspected AML

Omnia™ Uncovers Rare Patient Condition From Early Incidental Finding

Molecular Profiling Finds CALR Mutation in Patient with Persistent MPN and JAK2 History

High-Resolution Melting Assay For Rapid Simultaneous Detection Of JAK2, MPL And CALR Variants (AMP 2022 Poster)

Mutation Co-Expression Proven Insufficient in Monitoring CML Patient with Single BCR/ABL1 Fusion Isoform Testing

Omnia™ reveals previously undiagnosed CML in patients with a history of CLL

MPN Panel reveals a rare mutation and co-expression of JAK2 Exon 13 with CALR mutation

Precipio’s RevCI™ Procedure Delivers Conclusive Lymphoma Diagnosis

Myelodysplastic Syndrome Ruled Out For T-Cell Large Granular Leukemia

White Precipio Logo

About Us

Our Culture
News
Careers
Scientific Advisors
Management Team
Board of Directors

Products & Services

 

Hematopathology Services
Bloodhound BCR-ABL1
Bloodhound MPN
HemeScreen Reagents
IV-Cell Cytogenetics Media
Product Terms & Conditions

Links

 

Billing/Financial
HIPAA
Accreditations
Ethics
Statistics
Environment
Privacy Policy
Disclaimer

Contact

Email Us:

[email protected]

Call Us Today:

+1.203.787.7888

Arrow Top

Back To Top

My Account Shop Online CaseVu Login

Copyright 2025 © Precipio

  • $0.00
    • Cart

      No products in the cart.

      Return to shop

  • About Us
    • Our Culture
    • News
    • Careers
    • Scientific Advisors
    • Management Team
    • Board of Directors
  • Products
    • Molecular Kits
      • MPN Panel
      • BCR-ABL1 Panel
      • ABL1 Resistance Panel
      • Rapid AML Panel
      • CLL Panel
      • Cytopenia Panel
    • IV-Cell Cytogenetics Media
      • IV-Cell Cytogenetics Media
    • Resources
      • Brochures
      • Case Studies
      • Instructions For Use
      • Instructions For Use – CE (Europe)
      • Sample Reports
      • FAQs
  • Clinical Services
    • Hematopathology Services
      • Test Menu
      • Sample Reports
      • Proprietary Technologies
      • Meet Our Hematopathologists
    • Resources
      • Brochures
      • Case Studies
      • Sample Reports
      • FAQs
  • Investors
    • Press Releases
    • Media
    • SEC Filings
    • Subscription
    • Investor FAQs
    • Corporate Governance
    • Business Update Calls
    • ESG Policy
  • Contact
  • My Account
    • Login IconCaseVu
    • Login IconShop
    • Login IconPatient Bill Pay

Login

Lost your password?